Key Insights on the Classification and Theranostic Applications of Magnetic Resonance Imaging Contrast Agents
Authors:
- 6 February 2024
- journal article
- review article
- Published by Wiley in ChemMedChem
- Vol. 19 (8) , e202300521
Abstract
Magnetic resonance imaging (MRI) is a non‐invasive molecular imaging tool being extensively employed in clinical and biomedical research for the detection of a broad spectrum of diseases. This technique offers remarkable spatial resolution, good tissue penetration and a high soft tissue contrast. Contrast agents (CAs) have been regularly used in MRI tests to enhance the resolution of MR images and to visualize the diseased sites in the body. In the past years, considerable efforts have been devoted towards developing new theranostic MRI agents that can be tailored to integrate the targeting and therapeutic functions in a single agent. In this review, we have underlined the role of the MRI CAs in the developing field of ‘theranostics’ and their recent applications in the combined imaging and therapy of different types of tumors. In addition, this review also outlines the different categories of MRI CAs and their comprehensive classification based on different criteria such as chemical composition, relaxation mechanism and biodistribution with clinically relevant examples.Keywords
Funding Information
- Amity University
This publication has 96 references indexed in Scilit:
- Engineering Liganded Gold Nanoclusters as Efficient Theranostic Agents for Cancer ApplicationsChemBioChem, 2022
- Toward 18F‐Labeled Theranostics: A Single Agent that Can Be Labeled with 18F, 64Cu, or 177LuChemBioChem, 2019
- Glioma‐Targeted Delivery of a Theranostic Liposome Integrated with Quantum Dots, Superparamagnetic Iron Oxide, and Cilengitide for Dual‐Imaging Guiding Cancer SurgeryAdvanced Healthcare Materials, 2018
- Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic ApplicationsAdvanced Healthcare Materials, 2017
- Hexaphyrin as a Potential Theranostic Dye for Photothermal Therapy and 19F Magnetic Resonance ImagingChemBioChem, 2017
- A comparison of iopromide and iopamidol, two acidoCEST MRI contrast media that measure tumor extracellular pHContrast Media & Molecular Imaging, 2015
- A review of responsive MRI contrast agents: 2005–2014Contrast Media & Molecular Imaging, 2014
- Blood‐Pool and Targeting MRI Contrast Agents: From Gd‐Chelates to Gd‐NanoparticlesEuropean Journal of Inorganic Chemistry, 2012
- Classification and basic properties of contrast agents for magnetic resonance imagingContrast Media & Molecular Imaging, 2009
- High‐Relaxivity MRI Contrast Agents: Where Coordination Chemistry Meets Medical ImagingAngewandte Chemie International Edition, 2008